Tara L. Lancaster

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.

High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.

Journal: PloS one

Published: October 21, 2025

Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronaviruses.

Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronaviruses.

Journal: Communications biology

Published: September 02, 2025

Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI).

Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI).

Journal: Wellcome open research

Published: January 11, 2024

An Extracellular/Membrane-Bound S100P Pool Regulates Motility and Invasion of Human Extravillous Trophoblast Lines and Primary Cells.

An Extracellular/Membrane-Bound S100P Pool Regulates Motility and Invasion of Human Extravillous Trophoblast Lines and Primary Cells.

Journal: Biomolecules

Published: May 04, 2023

Immunological imprinting of humoral immunity to SARS-CoV-2 in children.

Immunological imprinting of humoral immunity to SARS-CoV-2 in children.

Journal: Nature communications

Published: February 19, 2023

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.

Journal: The lancet. Healthy longevity

Published: July 11, 2022

COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.

COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.

Journal: Cancer cell

Published: May 19, 2022

Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes.

Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes.

Journal: Nature aging

Published: May 10, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).

Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).

Journal: The Journal of infectious diseases

Published: February 01, 2022

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.

Journal: The lancet. Healthy longevity

Published: December 22, 2021

The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis.

The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis.

Journal: Biomolecules

Published: September 12, 2021

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.

Journal: The lancet. Healthy longevity

Published: August 25, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026